版本:
中国

BRIEF-Aurinia releases open-label AURION data for Voclosporin

Oct 6 Aurinia Pharmaceuticals Inc :

* Label AURION data demonstrating increased remission rates over time for Voclosporin in the treatment of Lupus Nephritis

* Complete remission rates increase to 70 pct in open-label study at 24 weeks

* Patients in remission at eight weeks remained in remission at 24 weeks Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐